Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DIA:CONN P8(Smart Insulin Pen) Study in Diabetes Patients

NCT: NCT06406439 · COMPLETED

NCT IDNCT06406439
StatusCOMPLETED
Start Date2024-05-21
Completion2025-04-02
SponsorG2e Co., Ltd (INDUSTRY)
First posted
Last updated

Brief Summary

A Multicenter, Open label, Randomized, Comparative Study to Evaluate the Efficacy and Safety of Electric Smart Insulin Pen DIA:CONN P8 in patients with Type 1, Type 2 or Pancreatogenic Diabetes Mellitus under Multiple Dose Insulin Therapy

Frequently Asked Questions

What is DIA:CONN P8(Smart Insulin Pen) Study in Diabetes Patients?

DIA:CONN P8(Smart Insulin Pen) Study in Diabetes Patients is a clinical trial registered under NCT06406439. Current status: COMPLETED.

What is the status of NCT06406439?

The current status of NCT06406439 (DIA:CONN P8(Smart Insulin Pen) Study in Diabetes Patients) is: COMPLETED.

When did DIA:CONN P8(Smart Insulin Pen) Study in Diabetes Patients start?

DIA:CONN P8(Smart Insulin Pen) Study in Diabetes Patients started on 2024-05-21.

Related Devices

K161950Common Type Insulin Pen Needle, Safety Type Insulin Pen NeedlePromisemed Hangzhou Meditech Co., Ltd. K202319Insulin Pen Needle (Ordinary Type), Insulin Pen Needle (Safety Type)Tianjin Huahong Technology Co., Ltd. K210065Verifine Safety Type Insulin Pen NeedlePromisemed Hangzhou Meditech Co., Ltd. K182387NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector)Novo Nordisk, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑